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Abstract
Stray neutrons generated in passively scattered proton therapy are of concern because they
increase the risk that a patient will develop a second cancer. Several investigations characterized
stray neutrons in proton therapy using experimental measurements and Monte Carlo simulations,
but capabilities of analytical methods to predict neutron exposures are less well developed. The
goal of this study was to develop a new analytical model to calculate neutron ambient dose
equivalent in air and equivalent dose in phantom based on Monte Carlo modeling of a passively
scattered proton therapy unit. The accuracy of the new analytical model is superior to a previous
analytical model and comparable to the accuracy of typical Monte Carlo simulations and
measurements. Predictions from the new analytical model agreed reasonably well with
corresponding values predicted by a Monte Carlo code using an anthropomorphic phantom.

1. Introduction
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The physical characteristics of proton beams make it possible to deliver a large and uniform
dose to the target while sparing normal tissue, which may reduce the risk of radiationinduced secondary cancer relative to that of photon therapy (Miralbell et al 2002,
Newhauser et al 2009, Fontenot et al 2009). The most common delivery method of proton
beams is passively scattered proton therapy (PSPT). In the process of shaping the beam to
the target during PSPT delivery, neutrons are produced in the treatment unit and in the
patient (Zheng et al 2007, 2008), resulting in the patient being exposed to a whole body
neutron dose about several hundred mSv (Newhauser et al 2009, Taddei et al 2009). The
relative biological effectiveness of these neutrons for carcinogenesis is not well known (Hall
2006). In order to estimate a patient’s risk of developing radiogenic secondary cancer from
the PSPT treatment, it is necessary to take into account the risk associated with the stray
neutron exposures throughout the patient.
Many investigators have studied the stray neutrons in proton therapy using experimental
measurements and Monte Carlo simulations (Binns and Hough 1997, Agosteo et al 1998,
Yan et al 2002, Schneider et al 2004, Roy and Sandison 2004, Polf and Newhauser 2005,
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Mesoloras et al 2006, Tayama et al 2006, Wroe et al 2007, Zytkovicz et al 2007, Zacharatou
Jarlskog et al 2008, Yonai et al 2008, Moyers et al 2008, Athar and Paganetti 2009, Shin et
al 2009, Zheng et al 2007, 2008, 2009, Newhauser et al 2009, Taddei et al 2009, PérezAndújar et al 2009). Marked variations of neutron dose equivalent per therapeutic-absorbed
dose (H/D) were found among studies, mainly because the stray neutron dose depends
heavily on the design of the treatment apparatus, measurement or calculation method and the
treatment technique.
Because of the complexity, cost and time required for both measurements and Monte Carlo
simulations, it would be desirable to have analytical models that could be used to predict the
H/D values in proton therapy or be used as an independent crosscheck of measured or
simulated results. Zheng et al (2007) described an analytical model capable of predicting H/
D values during PSPT. However, their model has only been tested against H/D values
calculated in air. It was not known how well an analytical model could predict H/D values in
a phantom.
The objective of this work was to develop an accurate analytical model to predict H/D
values both in air and in a simple water phantom from a PSPT treatment. Monte Carlo
methods were used to model the PSPT treatment unit and generate H/D values both in air
and in a phantom.
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2. Methods and materials
2.1. Monte Carlo simulations
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The Monte Carlo N-particle eXtended radiation transport code (MCNPX version 2.6,
Pelowiz 2005) was used to model the proton beam delivery system and simulate neutron
exposures. Nuclear interaction cross-section libraries were used for protons with energies
below150 MeV, while physics models were used at energies above 150 MeV. Figure 1
shows a schematic of the PSPT treatment unit and the layout of the neutron receptors. The
proton beam delivery system includes a vacuum window, a beam profile monitor, a range
modulator wheel, a second scatter, shielding plates, a range shifter assembly, backup and
primary monitors, the snout and the final aperture. The materials for each component can be
found in Newhauser et al (2007) and Zheng et al (2007). The simulation geometry utilized a
specifically defined condition: an unmodulated (i.e. pristine) 250 MeV proton beam incident
upon a medium size (18 × 18 cm2) closed aperture (to conservatively estimate H/D values).
The neutron absorbed dose was simulated in air in 2 cm diameter spherical receptors
oriented in both the z and x directions. We also simulated neutron dose in a 30 × 180 × 44
cm3 water phantom (to mimic a patient) introduced at the end of the beam line and centered
at the isocenter. The positions of spherical receptors were the same in simulations with and
without the water phantom. The in-house Monte Carlo Proton Radiotherapy Treatment
Planning (MCPRTP) code (Newhauser et al 2008) was used to generate all necessary input
files; the simulations were run with parallel processing on 2.6 GHz, 64 bit processors. For
more details of the geometric model of the PSPT treatment unit, the reader is referred to the
previous works (Newhauser et al 2007, 2008).
To verify predictions from the analytical model, we also used Monte Carlo simulations to
predict H/D values in a prostate treatment of a computational anatomical male phantom
(Billings and Yucker 1973). This phantom had been adapted for use in MCNPX and has
been used in previous studies in our group (Fontenot et al 2008, Taddei et al 2008,
Newhauser et al 2009). The phantom, shown in figure 2, was simulated with 2 cm diameter
spherical receptors in the organs of interest (brain, lungs, breast, stomach, liver, colon,
esophagus, thyroid, bladder, rectum, gonads and prostate).
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2.2. Calculation of H/D
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For simulations with the water phantom, the neutron absorbed dose per source particle, Dn/
sp, was scored in each receptor, and the neutron equivalent dose per source particle was
calculated using
(1)

where the mean radiation weighting factor
for neutrons was calculated following
methods previously reported by our group (Taddei et al 2008, Newhauser et al 2009).
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For simulations in air, the neutron ambient dose equivalent was simulated instead of using
the method of equation (1). This was done because the mean free path of neutrons in air is
much longer than the diameter of receptors and the interaction probability of neutrons and
their secondary particles inside receptors is very low. In contrast, scoring the neutron fluence
is more effective because the track length of neutrons is scored directly instead of simulating
neutron interactions and secondary particles tracks. Using the track-length estimate of
neutron fluence, it was possible to obtain Monte Carlo tally convergence, which was
essential for simulation results to be considered reliable, whereas convergence could not be
obtained in air using the method of equation (1). Neutron spectral fluence per source
particle, ΦE/sp, was simulated in each receptor (i.e. neutrons per cm2 per source proton) by
the Monte Carlo code. Each ΦE/sp was then converted to ambient neutron dose equivalent
per source proton (H/sp) values according to

(2)

where i is the index and n is the total number of neutron energy bins, and (H/Φ E)i and ΦEi/
sp were, respectively, the ambient dose equivalent per fluence and the neutron fluence per
source proton in the ith neutron energy bin. The conversion coefficients, (H/ΦE)i, were taken
directly from ICRP (1996).
The therapeutic absorbed dose per source particle (D/sp) for a reference condition was
calculated in separate simulations. The reference condition included a 10 × 10 cm2
collimated 250 MeV proton treatment field and the D/sp was determined on the central axis
of the beam at the center of the pristine Bragg peak in a water phantom. H/D values were
calculated by dividing H/sp by D/sp.
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3. Analytical models of H/D
An analytical equation was used to model H/D as a function of receptor location following
the method from Zheng et al (2007):

(3)

where d was the distance from the effective neutron source, which was found to be very
close to the final collimating aperture (Zheng et al 2007), to the neutron receptor, (H/D)d
was the H/D value at the neutron receptor, diso was a fitting parameter that indicated the
distance from the effective neutron source to isocenter, and p was the parameter describing
the shape of the dose falloff with distance. While their equation provided reasonable
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estimates of neutron dose equivalent in air, the presence of a water phantom has been shown
to strongly influence neutron dose distributions from PSPT (Zheng et al 2008, 2009).
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In this study, we generalized the model in equation (3) to predict H/D values both in air and
in a water phantom. Specifically the model includes terms for an attenuation factor (AF) and
an off-axis factor (OAF). The neutron dose decreases exponentially with depth in the
phantom, or
(4)

where α is a fitting parameter which describes the attenuating property of the phantom
material, and d′ is defined as the distance from the phantom surface to the neutron receptor
along the path between the effective neutron source and the neutron receptor (see figure 1).
In the lateral direction, the neutron dose distribution diverges and follows a Gaussian
distribution, or
(5)
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where x and y are the lateral distances from the dose receptor to the central axis and σ is the
fitted Gaussian width parameter.
The neutron spectral fluence has been observed to contain two pronounced peaks: a lowenergy evaporation peak ranging from 10 keV to around 10 MeV and a high-energy cascade
peak ranging from around 10 MeV up to the incident proton energy (cf Zheng et al 2008,
2009). Based on that knowledge, we proposed the following equation to estimate the H/D
value at position d in air:
(6)
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where C1 is a fitted empirical parameter that apportions the relative dose contributions from
high- and low-energy neutrons, p1 and p2 are the parameters governing dose falloff with
distance for high- and low-energy neutrons, respectively. σ1 and σ2 are the corresponding
Gaussian lateral width parameters, z is the axial coordinate for the neutron dose receptor and
is used to scale the width parameters (see figure 1). The differences between equations (3)
and (6) were that the neutrons were partitioned into two energy groups and the double
Gaussian approach, with the separate Gaussian items characterizing the high-energy cascade
neutrons and the low-energy evaporation neutrons.
Similarly, the H/D value in the water phantom was estimated using
(7)

where d′iso is the distance from the phantom surface to the isocenter, α1 and α2 characterize
the attenuation properties for the high- and low-energy neutrons, respectively. This equation
takes into account both divergence and attenuation of neutrons in the water phantom.
To facilitate calculation of d′ for the anthropomorphic phantom, we ‘enclosed’ the phantom
in an imaginary box that is slightly larger than the phantom itself and calculated d′ as if the
box were the phantom surface. Additionally, we approximated the tissue density within the
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anthropomorphic phantom as being identical to that of water when we predicted H/D values
using analytical models. However, in the Monte Carlo simulations, the more realistic
material and mass densities of the anthropomorphic phantom were used.

4. Results
Table 1 shows the values of the fit parameters from the previous analytical model (Zheng et
al 2007) and the new analytical model from this work. The diso value was intentionally fixed
at 33 cm, which is the distance from the final aperture to isocenter, because the majority of
protons were stopped at the final closed aperture. Most of the p values were less than 2,
which indicated that the neutron source was spatially distributed and not a point source. C1
values in the new model were less than 0.24, which indicated that more than two thirds of H/
D values were associated with low-energy evaporation neutrons. The σ2 values were much
larger than σ1 values, which indicated, as expected, that the low-energy evaporation
neutrons were isotropically emitted whereas the high-energy neutrons were emitted in a
forward cone centered about the central axis of the proton beam.
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Figure 3 plots predicted H/D values from Monte Carlo simulations and analytical models as
a function of vertical and lateral positions free in air. Near the central axis, both models fit
the simulated data well. The new model provided better agreement than the old model
farther away from the central axis. Figure 4 shows the predictions of H/D values from
Monte Carlo simulations and analytical models as a function of vertical and lateral positions
in the presence of a water phantom. The new analytical model showed better agreements at
all locations. The uncertainties in wR and fluence-to-dose conversion factors were large and
difficult to estimate, so they were taken as zero. The statistical uncertainties calculated by
MCNPX were 1.8% (mean) and 5.4% (maximum) for fluence simulations in figure 3, and
2.9% (mean) and 10.4% (maximum) for dose simulations in figure 4.
In air, the discrepancies between predictions of H/D values from Monte Carlo simulations
and analytical models were 2.56% (mean) and 12.6% (maximum) for the new analytical
model, and 20.8% (mean) and 48.8% (maximum) for the old model. The maximum absolute
discrepancy from Monte Carlo simulations was less than 5.1 mSv/Gy for both models. In the
water phantom, the discrepancies between predictions of H/D values from Monte Carlo
simulations and analytical models were 17.2% (mean) and 61.2% (maximum) for the new
analytical model, and 44.2% (mean) and 103.4% (maximum) for the old model. The
maximum absolute discrepancy from Monte Carlo simulations was less than 8.2 mSv/Gy for
both models.
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The H/D values in the anthropomorphic male phantom predicted using the Monte Carlo
method (statistical uncertainties calculated by the MCNPX code were reported at the 68%
confidence interval) and the analytical models are listed in table 2. These data revealed that
predictions from both analytical models agreed reasonably well with simulated data. The
discrepancy in H/D values was less than 55% for the new analytical model. The largest
discrepancy was in the brain and this is possibly because the discrepancy between the real
phantom surface and the imaginary box surface was the largest in the region of the head.
This discrepancy would decrease to 22% if the d′ was reduced by half. The results were
reasonably good, however, given the simplified treatment of the anatomical phantom surface
and tissue densities in the calculation. Preliminary tests showed that the calculated results
from the new analytical model were sensitive to the d′ parameter, which is related to
differences in the shapes and locations of the water phantom and the anthropomorphic
phantom surfaces.

Phys Med Biol. Author manuscript; available in PMC 2010 December 13.

Zhang et al.

Page 6

5. Discussion
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We developed a simple analytical model to predict H/D values in air and a water phantom
for PSPT. The analytical model takes into account two distributed sources, neutron dose
divergence, attenuation and scatter. The results of our study show that the accuracy of the
new analytical model is comparable to the accuracy of typical neutron simulations or
measurements.
In air, both the analytical model from Zheng et al (2007) and the new model developed in
this work predicted H/D well near the central axis, while the new model provided better
accuracy farther from the central beam axis. These findings revealed that an OAF correction
should be taken into account. With the introduction of a water phantom, the new model gave
overall better agreement than the old analytical model near the central axis regions and in
distal regions. These results revealed that the AF and OAF correction are necessary. Overall,
the result of this study suggest the potential for a simple analytical model to predict H/D
values, in air or a water phantom, with sufficient accuracy for many practical research
applications.
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The analytical models provided reasonable accuracy in predicting H/D values in an
anatomical male phantom with simplified phantom surface and uniform tissue density. We
did not attempt to take into account the irregularity of real patient surface or variations in
tissue density, as are routinely accomplished with ray tracing in commercial treatment
planning systems. However, the simple model is applicable for estimation of H/D values in
air or in box-shaped phantoms. Our study had several limitations. First, we only calculated
H/D values based on a 250 MeV pristine proton beam, while most treatments utilize a
spread-out Bragg peak (SOBP). However, previous studies showed that the effect of SOBP
width is relatively small (Zheng et al 2008). Future studies are needed to extend the
analytical model to take into account different treatment options such as beam energies, field
size and spread-out Bragg peak width. Second, we only used a closed aperture in the
simulations for simplicity, and it is also a conservative estimation of stray neutron dose
(Zheng et al 2007, 2009). Third, our model is based on the PSPT unit at our institution;
however, the modeling method reported here should be applicable with minor adaptation to
other PSPT units.
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Our method may find application in estimating out-of-field patient dose and in shielding
requirements, especially in situations where measurements or Monte Carlo modeling are not
feasible. Even when other dose estimation methods are feasible, the analytical model can
also be used as an independent cross-check. Another potential application of our model is to
extend the capability of current commercial treatment planning systems to calculate the outof-field dose delivered to the patient during radiation treatment. The stray radiation
exposures calculated by the analytical model may eventually be used in personalized patient
risk assessments.
Although our study focused on PSPT, it might be possible to extend our model to spot
scanning proton therapy. With the Monte Carlo method, it is possible to separate neutron
dose into external neutrons and internal neutrons (Taddei et al 2009). However, the size and
location of sources of internal neutrons (the predominant source in spot scanning beams) are
highly variable and may pose considerable challenges to the model analytically.
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Figure 1.

Schematic illustration of the PSPT treatment nozzle and the water phantom. The nozzle
includes a vacuum window (A), a beam profile monitor (B), a range modulator wheel (C), a
second scatter (D), shielding plates (E), a range shifter assembly (F), backup and primary
monitors (G), the snout (H) and the final aperture (I). Neutron dose was calculated in 2 cm
diameter spherical receptors (open circles) in both axial (z) and lateral (x) directions. In the
figure, d indicates the distance from the effective neutron source to the neutron receptor, d′
indicates the distance from the phantom surface to the neutron receptor along the path
between the effective neutron source and the receptor, diso indicates the distance from the
effective neutron source to the isocenter. The figure is not drawn to scale.
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Figure 2.
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Schematic illustration of the PSPT treatment unit and the computational anatomical male
phantom modeled using Monte Carlo simulations. The locations of the neutron dose
receptors are shown as yellow circles on the phantom. The dash line box represents the
imaginary box used to enclose the phantom for calculation convenience. The figure is not
drawn to scale. (Rendering of anthropomorphic phantom was provided courtesy of Tom
Jordan.)
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Results from Monte Carlo simulations and analytical models predictions of ambient neutron
dose equivalent per therapeutic dose (H/D) free in air as a function of vertical distance (a)
and (b) and lateral distance (c). These values were for a specific condition (an unmodulated
250 MeV proton beam incident upon a medium-sized closed aperture). Analytical model
(new) is from this study, analytical model (old) is from Zheng et al (2007).
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Figure 4.
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Results from Monte Carlo simulations and analytical models predictions of neutron
equivalent dose per therapeutic dose (H/D) in the water phantom as a function of vertical
distance (a) and (b) and lateral distance (c). These values were for a specific condition (an
unmodulated 250 MeV proton beam incident upon a medium-sized closed aperture).
Analytical model (new) is from this study, analytical model (old) is from Zheng et al (2007).
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Fitting parameters for the analytical models (analytical model (new) is from this study, analytical model (old)
is from Zheng et al (2007)) for the specific condition (an unmodulated 250 MeV proton beam incident upon a
medium-sized closed aperture. The aperture was closed for both in-air and water phantom cases). Dashes
indicate that parameters were not used in the given situation.
Analytical model (old)

Analytical model (new)

Parameter

Air

Water phantom

Air

Water phantom

diso

33

33

33

33

p1

1.30

2.0

1.0

1.0

p2

–

–

1.45

2.0

C1

–

–

0.20

0.24

α1

–

–

–

0.01

α2

–

–

–

0.017

σ1

–

–

15.85

9.18

σ2

–

–

820.34

1011.07
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d
(cm)
85.62
33.02
49.74
59.41
50.61
40.46
33.81
59.26
33.43
33.47
50.59
36.54

Organs

Brain

Prostate

Right lung

Left lung

Stomach

Liver

Colon

Esophagus/thyroid

Bladder

Rectum

Breast

Gonads

28.05

35.68

25.35

25.32

43.97

23.60

28.01

40.49

47.82

33.82

25.01

64.86

d′
(cm)

4.36 ± 0.074

2.01 ± 0.066

5.75 ± 0.085

6.36 ± 0.089

1.31 ± 0.06

4.69 ± 0.081

2.59 ± 0.066

1.78 ± 0.051

1.15 ± 0.056

1.78 ± 0.082

5.99 ± 0.088

0.76 ± 0.04

H/DMC
(mSv/Gy)

4.14

1.61

5.61

5.57

1.02

4.43

2.86

1.50

0.95

1.72

5.98

0.34

H/Dcal
(mSv/Gy)

4.99

20.06

2.45

12.39

22.35

5.65

10.52

15.65

17.34

3.76

0.00

54.76

Diff
(%)

Analytical model
(new)

4.89

2.55

5.82

5.84

1.86

5.71

3.99

2.55

1.85

2.64

5.98

0.89

H/Dcal
(mSv/Gy)

12.14

26.72

1.26

8.22

41.36

21.64

54.02

43.44

60.28

47.92

0.00

16.95

Diff
(%)

Analytical model
(old)

H/D values in the anatomical male phantom from Monte Carlo simulations (H/DMC) with statistical uncertainties, analytical calculations (H/Dcal) and the
absolute percentage differences between Monte Carlo and analytical predictions. These values were for a specific condition (an unmodulated 250 MeV
proton beam incident upon a medium-sized closed aperture). Analytical model (new) is from this study, analytical model (old) is from Zheng et al (2007).
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